| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000002489 |
| Receipt No. | R000003052 |
| Official scientific title of the study | Effect of beta blockers for prevention of atrial fibrillation after CABG: a randomised controlled trial |
| Date of disclosure of the study information | 2009/09/15 |
| Last modified on | 2018/03/26 (Ver. 14) |
| Basic information | ||
| Official scientific title of the study | Effect of beta blockers for prevention of atrial fibrillation after CABG: a randomised controlled trial | |
| Title of the study (Brief title) | BABYLON trial | |
| Region |
|
|
| Condition | ||
| Condition | myocardial infarction, angina | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the anti-arrhythmic effect of beta blockers in patients with atrial fibrillation after cardiac surgery |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Incidence of postoperative atrial fibrillation |
| Key secondary outcomes | 1) age
2) Blood pressure, heart rate, CVP 3) CK-MB, Tp-I, H-FABP 4) hs-CRP 5) ADMA 6) Pentraxin 3 7) mortality, complication 8) Ejection fraction (UCG), BNP 9) catecholamine |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | intra-and perioperative administration of landiolol hydrochloride (+)
postoperative administration of bisoprolol (+) |
|
| Interventions/Control_2 | intra-and perioperative administration of landiolol hydrochloride (+)
postoperative administration of bisoprolol (-) |
|
| Interventions/Control_3 | intra-and perioperative administration of landiolol hydrochloride (-)
postoperative administration of bisoprolol (-) |
|
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient undergoing isolated CABG
patients from whom informed consent was obtained |
|||
| Key exclusion criteria | past of arrhythmia
cardiogenic shock NYHA class IV congestive heart failure despite treatment sinus bradycardia at rest (<50/min) second -or third-degree AV block clinical hypothyroidism or hyperthyroidism Doctor's decision not to register to this regimen |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Akira Sezai |
| Organization | Nihon University School of medicine |
| Division name | Department of Cardiovascular Surgery |
| Address | 30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan |
| TEL | 03-3982-8111 |
| asezai.med@gmail.com | |
| Public contact | |
| Name of contact person | Akira Sezai |
| Organization | Nihon University School of Medicine |
| Division name | Department of Cardiovascular Surgery |
| Address | 30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan |
| TEL | 03-3972-8111 |
| Homepage URL | |
| asezai.med@gmail.com | |
| Sponsor | |
| Institute | Nihon University school of medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003052 |